16:02 Dec 20
Gland Pharma Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Gland Pharma Ltd.
46/100 Medium Financial Strength
Quality35/100 Mid Valuation
Valuation41/100 Technically Neutral
TechnicalSWOT
Strength
4
Weakness
7
Opportunity
1
Threat
0
29.20K
Market Cap (Cr)
42.22
PE Ratio
3.32
Price to Book Ratio
RSI
13.63 %
Net Profit Margin
Rating Based on 2 Analysts
Buy
50%
Hold
50%
Sell
0%
Buy
Analyst Price Target
The average price target is 2100 with a high estimate of 2440 and low estimate of 1760
Current 1772.30
Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation
SWOT
Download Our App On:
